Showing results (331-340 of 651) with videos related to
Sort By:
Pageof 66
JACC. Advances|February 28, 2025
Finerenone Efficacy in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Anemia in FIDELITYAjay K Singh, Glen James, Stefan D Anker, et al.Diabetes Care|December 27, 2023
Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin ResistanceThomas Ebert, Stefan D Anker, Luis M Ruilope, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetesNiels S Heinrich, Simone Theilade, Signe A Winther, et al.Scientific Reports|January 23, 2020
Describing the fecal metabolome in cryogenically collected samples from healthy participantsKajetan Trošt, Linda Ahonen, Tommi Suvitaival, et al.Journal of Diabetes and Its Complications|October 15, 2024
Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminuria levels in type 2 diabetes with no history of clinical cardiovascular diseaseLuis F Ferreira-Divino, Christina G Poulsen, Viktor Rotbain Curovic, et al.Cardiovascular Diabetology|May 21, 2015
Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetesBernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, et al.Journal of Diabetes and Its Complications|December 8, 2024
Kidney fat by magnetic resonance spectroscopy in type 2 diabetes with chronic kidney diseaseNiels Sondergaard Heinrich, Rune Ploegstra Pedersen, Mark Bitsch Vestergaard, et al.Renal Failure|May 25, 2026
Complication rates of 16- and 18-gauge needles for native kidney biopsies: a systematic review and proportional meta-analysisMarie Møller, Tue H Andersen, Rikke Borg, et al.Diabetes Care|July 3, 2019
Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 DiabetesSascha Pilemann-Lyberg, Daniel Guldager Kring Rasmussen, Tine Willum Hansen, et al.Advances in Therapy|May 30, 2026
Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi ConsensusYehuda Handelsman, Alice Y Y Cheng, Gian Paolo Fadini, et al.Pageof 66